These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 25691688)

  • 41. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
    Schiattarella GG; Sannino A; Esposito G; Perrino C
    Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
    Chambers ES; Preston T; Frost G; Morrison DJ
    Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbiome as a novel cardiovascular therapeutic target.
    Singh V; Yeoh BS; Vijay-Kumar M
    Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
    Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases.
    Li Y; Han S
    Gastroenterol Clin North Am; 2024 Sep; 53(3):383-397. PubMed ID: 39068001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of metagenomics in the human gut microbiome.
    Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
    World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut microbiota in cardiovascular disease and heart failure.
    Kitai T; Tang WHW
    Clin Sci (Lond); 2018 Jan; 132(1):85-91. PubMed ID: 29326279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human gut microbiome and body metabolism: implications for obesity and diabetes.
    Devaraj S; Hemarajata P; Versalovic J
    Clin Chem; 2013 Apr; 59(4):617-28. PubMed ID: 23401286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the gut microbiome and its metabolites in metabolic diseases.
    Wu J; Wang K; Wang X; Pang Y; Jiang C
    Protein Cell; 2021 May; 12(5):360-373. PubMed ID: 33346905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary metabolomic changes and microbiotic alterations in presenilin1/2 conditional double knockout mice.
    Gao J; Zhou N; Wu Y; Lu M; Wang Q; Xia C; Zhou M; Xu Y
    J Transl Med; 2021 Aug; 19(1):351. PubMed ID: 34399766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
    Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
    Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.
    Shoaie S; Ghaffari P; Kovatcheva-Datchary P; Mardinoglu A; Sen P; Pujos-Guillot E; de Wouters T; Juste C; Rizkalla S; Chilloux J; Hoyles L; Nicholson JK; ; Dore J; Dumas ME; Clement K; Bäckhed F; Nielsen J
    Cell Metab; 2015 Aug; 22(2):320-31. PubMed ID: 26244934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone.
    Song J; Ma W; Gu X; Zhao L; Jiang J; Xu Y; Zhang L; Zhou M; Yang L
    J Transl Med; 2019 Jul; 17(1):224. PubMed ID: 31307473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Danggui Buxue Tang restores antibiotic-induced metabolic disorders by remodeling the gut microbiota.
    Du R; Bei H; Jia L; Huang C; Chen Q; Tao C; Chen J; Bo H
    J Ethnopharmacol; 2020 Sep; 259():112953. PubMed ID: 32407936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.